Private label ·
Building a private-label ENT medical device range: which indications should it cover?
A coherent ENT range brings together products whose role is clear to both distributor and user. Choose the indications before deciding how many products to offer: each product should address an identified need.
Start with the indications already covered
List the products you distribute, their indications and their users. This helps distinguish a genuine gap from a general wish to expand the catalogue. A new presentation does not necessarily create a new use.
For each project, identify the territory and distribution channel. This information helps VITROBIO assess commercial availability. It does not replace checking the applicable status in the target country.
Separate nasal needs, throat conditions and cough
The VITROBIO catalogue includes products for allergic rhinitis, rhinopharyngitis and rhinosinusitis, acute pharyngitis and acute cough. These indications are not interchangeable and must retain their specific scope.
- Allerspray: treatment and prevention of allergic rhinitis, within its intended purpose.
- Nesospray: rhinopharyngitis and rhinosinusitis.
- Pharyndol Protect: symptomatic treatment of mild to moderate acute pharyngitis of viral or bacterial origin.
- CoughSpray Protect: acute productive and dry cough, in the population defined for this product.
This list supports a portfolio discussion. It is not treatment advice and does not cover every condition of use. Ages, precautions, instructions and clinical data must be checked for each product.
Give each product a clear role
One person may have several symptoms, but this does not justify automatically combining several devices. When designing your range, describe what each product covers and which claims it does not support.
Coherence comes from indications and accurate messages. A distributor should be able to explain a product’s role without extending the benefits of the technology to the whole range. Our article on assessing clinical data suggests questions to ask before using results in your materials.
Distinguish available products from developments
A project announced on the website has a different status from a marketed device. The cough and sore throat syrup is presented as being in development: it should not be included in a launch plan as an immediately available product.
Likewise, commercial terms for an existing product need confirmation for your territory. VITROBIO’s private-label offering is based on formulations already developed and evaluated; it does not include designing a new formula on request to fill a portfolio gap.
Prepare a shortlist rather than an entire catalogue
For the first discussion, select a few priority indications and explain their place in your business. Include target markets, forecast volumes and presentation constraints. The teams can then discuss products, documentation and the steps to clarify before a decision.
The nasal spray project brief provides a more detailed example for one product family. The Market our devices under your brand page explains the partnership and the information to provide.